Multiplex In Situ Proximity Ligation Assay Profiling of Immune Checkpoint Complexes in Clear-Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab: An Exploratory Study (ESMO-IO 2026) - Oct 25, 2026 - Abstract #51P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Oncology • Solid Tumor
|
|
Osama Hamida; Katalin Fekete; Frida Tallqvist; Mathias Franzen; Elin Vinsland; Agata Z. Wicher; Andreas Lundqvist; Lisa L. Liu Burström
|